Viveve Medical Inc expected to post a loss of 65 cents a share - Earnings Preview

Viveve Medical

10/08/2021 22:59

* Viveve Medical Inc  VIVE.OQ   VIVE.O  is expected to show a
rise in quarterly revenue when it reports results on August 12. 
* The Englewood, Colorado-based company is expected to report 
 a 116.6% increase in revenue to $1.525 million from $704
thousand a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Viveve Medical Inc is
for a loss of 65 cents per share. For the same quarter last
year, the company reported a loss of $4.40 per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Viveve Medical
Inc is $9.63​, about 74.6% above​ its last closing price
of $2.44. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.52       -0.51      -0.80     Missed  -56.9
 Dec. 31 2020  -2.69       -2.59      -1.85     Beat    28.7
 Sep. 30 2020              -5.30      -2.60     Beat    50.9​
 Jun. 30 2020  -5.90       -5.90      -4.40     Beat    25.4
 Mar.          -126.00​    -126.00    -8.20     Beat    93.5​
 31​ 2020​                                              
 Dec. 31 2019              -12.40     -43.77    Missed  -253​
 Sep. 30 2019  -160.00     -160.00    -135.10   Beat    15.6
 Jun. 30 2019  -173.72     -178.33    -210.00   Missed  -17.8
 This summary was machine generated August 10 at 21:59 GMT.  All
figures in US dollars unless otherwise stated